Clinical Trial Update: A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Pfizer conducted a Phase 2 trial of SU011248 in locally advanced or metastatic non-small cell lung cancer; results from the completed study were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• SU011248

Snippet

Sponsor: Pfizer | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2010-05-10